Regular availability of Mpox vaccinations
Keepin' It Real: Mpox Vaccination Info for You
Here's the lowdown on the IMVANEX® vaccine for Mpox protection, freshly available in Gemany. Medical practices can cop it through pharmaceutical wholesalers and pharmacies.
The Ministry of Health and the Association of Statutory Health Insurance Physicians in Saarland want insured folks with the right risk factors (or 'indications') to know they're entitled to the Mpox jab, which is covered by health insurance. Starting April 1, 2023, this vax was included in Saarland's regional vaccination agreements.
Two groups in particular are prioritized for the Mpox vaccination:
- People with increased exposure and infection risk, like men over 18 who dig other dudes (MSM) and switch partners often.
- Workers in specialized labs who deal with infectious samples containing Monkeypox material, declared at risk by an individual risk assessment.
Since the sweltering summer of 2022, JYNNEOS® vax jabs (almost the same as IMVANEX®, but not quite) have been given out via off-label use, badass healthcare pros working their magic before IMVANEX® hit the EU scene.
Over 200 doses have been administered in Saarland, where appointments were set at the University Clinics with the help of HIV specialist practices, Aidshilfe Saar e.V., and local health authorities. By keeping the risk groups fully informed and trackin' down cases, larger outbreaks in Saarland were avoided. The last case in the land happened in August 2022, with 13 cases documented in total.
Dr. Magnus Jung, Germany's Health Minister, salutes all the dedicated folks who whipped up a vaccination infrastructure in record time, helping crush the summery outbreak.
Though the global health emergency ended, a fresh outbreak wave isn't out of the question. So, peeps in the risk group, check your risk factors and get your self vaccinated!
For more details, hit up local health authorities or the German Federal Ministry of Health to get the scoop on vaccination coverage under statutory health insurance.
Enrichment insights:- The European Centre for Disease Prevention and Control (ECDC) suggests combining primary preventive and post-exposure preventive vaccination strategies to protect people at higher risk of exposure, such as gay, bisexual, and transgender folks, MSM, and individuals with occupational exposure.- JYNNEOS (MVA-BN) is an approved Mpox vaccine in the EU and has shown effectiveness in prevention.- As of May 2025, Germany reported 33 Mpox cases, indicative of ongoing Mpox management efforts.
Engage with local health authorities or the German Federal Ministry of Health for comprehensive information on Mpox vaccination coverage under statutory health insurance, as they strive to protect high-risk groups such as individuals with occupational exposure to the virus, including those in scientific fields working with Monkeypox material. It's important to note that the European Centre for Disease Prevention and Control (ECDC) highlights the importance of combining primary preventive and post-exposure preventive vaccination strategies for individuals at increased risk, such as gay, bisexual, and transgender people, as well as sexually active men who have multiple partners.
